Androgen deprivation therapy (ADT) and androgen receptor (AR)-targeted therapy are the
gold standard options for treating prostate cancer (PCa). These are initially effective, as …

Abstract β‐catenin‐mediated Wnt signaling is an ancient cell‐communication pathway in
which β‐catenin drives the expression of certain genes as a consequence of the trigger …

Prostate cancer (PC) is the second most common cancer in men worldwide. Due to the large-
scale sequencing efforts, there is currently a better understanding of the genomic landscape …

Simple Summary Prostate cancer can develop under hormone treatment and chemotherapy
from a castration-sensitive towards a castration-resistant into a drug resistant-tumor. The …

Abstract Background Prostate cancer (PCa) is an age-related malignancy in men with a high
incidence rate. PCa treatments face many obstacles due to cancer cell resistance and many …

Prostate cancer is the most common type of cancer among men and the second most
frequent cause of cancer-related mortality around the world. The progression of advanced …

Simple Summary Thyroid cancer is the most common endocrine malignancy and occurs
three times more frequently in women than in men. Further, androgen receptor expression is …

Androgenetic alopecia (AGA) is the most common type of hair loss and features progressive
miniaturization of hair follicles. Generally, the occurrence of AGA has long been thought to …

Castration-resistant (androgen-independent) and PTEN-deficient prostate cancer is a
challenge in clinical practice. Sorafenib has been recommended for the treatment of this …

Background Despite being the second most common tumor in men worldwide, the tumor
metabolism-associated mechanisms of prostate cancer (PCa) remain unclear. Herein, this …